99% Savings - Buy Just @1 Rs X
Relibeta is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Relibeta safe for pregnant women?
Relibeta can have harmful effects in pregnant women. If you experience any discomfort after using Relibeta, then discontinue the use and take your doctor's advice.
Is the use of Relibeta safe during breastfeeding?
Relibeta may have very limited harmful effects for breastfeeding women.
What is the effect of Relibeta on the Kidneys?
Relibeta may have mild side effects on the kidneys.
What is the effect of Relibeta on the Liver?
Relibeta has very mild side effects on the liver.
What is the effect of Relibeta on the Heart?
Relibeta has very mild side effects on the heart.
Relibeta should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Relibeta unless your doctor advises you to do so -
Is this Relibeta habit forming or addictive?
Relibeta does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Relibeta you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Relibeta is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Relibeta in mental disorders is not effective.
Interaction between Food and Relibeta
Taking Relibeta with food does not cause any problems.
Interaction between Alcohol and Relibeta
Consult your doctor before consuming alcohol while taking Relibeta as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 701-702
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avonex (interferon beta-1a)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rebif® (interferon beta-1a)